Skip to search.
 TSX Up 2.43% TSX Ventures Up 0.55%

Delcath Systems, Inc. (DCTH)

-NasdaqCM
0.27 Up 0.01(4.29%) Feb 12, 3:17PM EST
Prev Close:0.26
Open:0.27
Bid:N/A
Ask:0.56 x 800
1y Target Est:1.30
Beta:1.12971
Next Earnings Date:N/A
Day's Range:0.26 - 0.28
52wk Range:0.25 - 1.92
Volume:21,310
Avg Vol (3m):147,911
Market Cap:5.93M
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
DCTHUp 4.29%5.93M
LLYDown 0.21%75.47B
PFEUp 0.79%181.25B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:4.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback